These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15854021)

  • 21. [Reporting melanocytic lesions: the form, substance, and the void].
    Urso C
    Pathologica; 2001 Jun; 93(3):253-7. PubMed ID: 11433624
    [No Abstract]   [Full Text] [Related]  

  • 22. A coarse-to-fine approach for segmenting melanocytic skin lesions in standard camera images.
    Cavalcanti PG; Scharcanski J
    Comput Methods Programs Biomed; 2013 Dec; 112(3):684-93. PubMed ID: 24075079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Histological spectrum of malignant melanoma].
    Brenn T
    Pathologe; 2015 Feb; 36(1):53-61. PubMed ID: 25589353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for ErbB4 gene amplification in malignant melanoma.
    Brockhoff G; Bock M; Gantner S; Hafner C
    Acta Derm Venereol; 2011 Jun; 91(4):488-90. PubMed ID: 21547347
    [No Abstract]   [Full Text] [Related]  

  • 25. Cover Image: Invasion of a cutaneous melanoma tumour.
    Hill D; Lovat P
    Br J Dermatol; 2017 Aug; 177(2):599. PubMed ID: 28833009
    [No Abstract]   [Full Text] [Related]  

  • 26. Performance of the First Step of the 2-Step Dermoscopy Algorithm.
    Chen LL; Dusza SW; Jaimes N; Marghoob AA
    JAMA Dermatol; 2015 Jul; 151(7):715-21. PubMed ID: 25714607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Step-wise expression of melanoma-associated antigens in tumor progression].
    Lehmann JM; Holzmann B; Rothbächer U; Riethmüller G; Johnson JP
    Onkologie; 1989 Dec; 12(6):273-6. PubMed ID: 2696911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intraepidermal distribution patterns of melanocytes in the melanocytic lesions on the sole: proposed criteria for histopathologic diagnosis of plantar malignant melanoma in situ].
    Saida T; Yoshida N
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):553-60. PubMed ID: 2585770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spitzoid melanoma.
    Kamino H
    Clin Dermatol; 2009; 27(6):545-55. PubMed ID: 19880042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasitism of basal cell carcinoma by lentigo maligna melanoma.
    Wang H; Benda PM; Piepkorn MW
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S92-4. PubMed ID: 12734489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borderline and atypical melanocytic lesions.
    Brodell RT; Santa Cruz DJ
    Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphological prognostic criteria in skin melanoma].
    Parshikova SM; Khasanov ShR
    Vopr Onkol; 1991; 37(3):283-8. PubMed ID: 2031322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the microenvironment on melanoma cell fate determination and phenotype.
    Postovit LM; Seftor EA; Seftor RE; Hendrix MJ
    Cancer Res; 2006 Aug; 66(16):7833-6. PubMed ID: 16912153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
    Strauss RM; Elliott F; Affleck P; Boon AP; Newton-Bishop JA
    Br J Dermatol; 2007 Oct; 157(4):758-64. PubMed ID: 17714559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Implications of the clinico-pathological types, levels of invasion and maximum thickness of tumors].
    Rodríguez-Martínez HA
    Gac Med Mex; 1985; 121(11-12):321-6. PubMed ID: 3842366
    [No Abstract]   [Full Text] [Related]  

  • 39. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.